Abstracts

MTDNA HAPLOGROUP B IS ASSOCIATED WITH EXECUTIVE FUNCTION AND RECALL IN HISPANIC PLWH

Neurocognitive impairment (NCI) is common among persons living with HIV (PLWH) and impacts quality of life and functional status. Mitochondrial DNA (mtDNA) haplogroups are associated with HIV-related outcomes. NCI appears to be more frequent in persons of Hispanic ethnicity with HIV. We previously observed less NCI in Hispanic-ancestry PLWH having mtDNA haplogroup B. The current…

MECHANISMS OF WHITE-MATTER LOSS DUE TO HIV INFECTION AND ANTIRETROVIRAL THERAPY

White matter pathologies including corpus callosum thinning and disruption of white matter microstructures persist in HIV-positive patients on combination antiretroviral (ARV) therapy (cART). Thinning of the corpus callosum increases with time on cART. Thus, we hypothesized that HIV-infected macrophages and/or antiretroviral compounds alter oligodendrocyte differentiation, function, and/or survival and sought to identify the mechanism underlying…

SWITCHING TO FTC/TAF FROM ABC/3TC OR FTC/TDF DOES NOT AFFECT CNS HIV-1 INFECTION

Despite suppressive antiretroviral therapy (ART), many HIV-infected individuals have low-level persistent immune activation in the central nervous system (CNS). Emtricitabine/tenofovir disoproxil fumarate (FTC/TDF) and abacavir/lamivudine (ABC/3TC) have been the most widely used nucleoside analogues for several years. In 2015, when this study was initiated, a new prodrug for tenofovir, tenofovir alafenamide fumarate (TAF), was introduced.…

POLYPHARMACY IS ASSOCIATED WITH WORSE NEUROCOGNITIVE PERFORMANCE IN AGING ADULTS

Persons living with HIV (PLWH) have more aging-related diseases, use more prescribed drugs, and are more likely to have neurocognitive (NC) impairment than the general population. Medical and psychiatric comorbidities increase risk of NC impairment in PLWH but the neurotoxicity of drugs used to treat these diseases remains underinvestigated. 956 PLWH taking antiretroviral therapy (ART)…

EARLY ART IN ACUTE HIV LIMITS DETRIMENTAL CX3CR1 MONOCYTES LINKED TO CNS DYSFUNCTION

CX3CR1 on immune cells drives tissue homing. In chronic HIV (CHI), inflammatory and patrolling monocytes express reduced CX3CR1 density compared to uninfected (HIV-) controls. In addition, CX3CR1 on microglia has been reported to have neuromodulatory effects in the brain. We investigated the dynamics of CX3CR1 density on monocyte subpopulations in individuals who initiate combination antiretroviral…

INFLUENCE OF UGT1A1*28 ON RALTEGRAVIR PK/PD IN THE NEAT001/ANRS143 STUDY

Raltegravir (RAL) is metabolised by UGT1A1 and polymorphisms in the UGT1A1 gene have been associated with plasma concentrations in some but not all previous studies. This analysis represents the largest study to date for the effect of UGT1A1 polymorphisms on RAL PK/PD. NEAT001/ANRS143, a randomised study (n=805 participants), demonstrated non-inferiority of first-line darunavir/ritonavir (DRV/r; 800/100…

HORMONAL CONTRACEPTIVES DO NOT ALTER CABOTEGRAVIR PK IN HIV-UNINFECTED WOMEN HPTN 077

Long-acting Injectable Cabotegravir (CAB LA) is a novel strand-transfer integrase inhibitor, currently in development for HIV prevention and treatment. Unexpected drug-drug interactions (DDI) between ARVs and hormones for contraception or cross-sex therapy have been noted for other ARVs, ranging from 13% to 38% reduction in tenofovir exposure (AUC) in the setting of estrogen with or…